Top papers

Title Total views
Anemia in chronic heart failure: pathogenetic mechanisms. 16,677
Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume 16,621
Inhibitory Effect of Thymol on Suicidal Erythrocyte Death 16,411
Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial 16,407
A Computational Model of the Human Left-Ventricular Epicardial Myocyte 16,330
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. 16,296
Inhibition of induced chemoresistance by cotreatment with (E)-5-(2-bromovinyl)-2'-deoxyuridine (RP101). 16,291
Thyroid hormone improves the mechanical performance of the post-infarcted diabetic myocardium: A response associated with up-regulation of Akt/mTOR and AMPK activation 16,241
A model for human ventricular tissue 16,180
Drug Target Identification Using Side-Effect Similarity 16,171
Clinical Analysis on Alteration of Thyroid Hormones in the Serum of Patients with Acute Ischemic Stroke 16,112
Relationship of circulating C-reactive protein levels to thyroid status and cardiovascular risk in hyperlipidemic euthyroid subjects: low free thyroxine is associated with elevated hsCRP. 16,092
Report of WHO/UNICEF/UNU consultation on indicators and strategies for iron deficiency and anemia programmes 16,047
Anemia associated with chronic heart failure: current concepts 16,024
Risk of bias in meta-analysis on erythropoietin-stimulating agents in heart failure 15,967
The Economic Burden of Anemia in Heart Failure 15,922
Molecular Basis for Certain Neuroprotective Effects of Thyroid Hormone 15,921
Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. 15,920
C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death 15,815
Intracellular pathways of iodothyronine metabolism 15,804
Mechanisms behind the non-thyroidal illness syndrome: an update 15,750
Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis 15,744
Automation and validation of a fast method for the assessment of in vivo oxidative stress levels 15,657
Neuroprotective actions of thyroid hormones and low-T3 syndrome as a biomarker in acute cerebrovascular disorders 15,587
Iron status in patients with chronic heart failure 15,566

Pages

more
# File Name Number of Downloadssort ascending
1 012012_Repositioned_Drugs_List.xlsx 14448
2 BMDJ_template_Policy_paper_16.docx 13465
3 BMDJ_template_Editorial_16.docx 11070
4 BMDJ_template_Modelling_paper_16.docx 10995
5 BMDJ_template_Data_paper_16.docx 10720
6 BMDJ_template_Commentary_16.docx 9425
7 bmdj.01102_ec_oa_policy_horizon2020.pdf 8552
8 bmdj.01301_Mice_Myocardial_Infarction.pdf 7571
9 bmdj.01103_comp_modelling_cancer.pdf 7457
10 01300_Heart_Failure_and_Stress_Response.pdf 7260
11 bmdj.01304_Vassalle_Anaemia_Predictor.pdf 6782
12 bmdj.01303_Circulatory_modelling.pdf 6694
13 bmdj.01305_Cardiac_Magnetic_Resonance_Imaging.pdf 6311
14 bmdj.01302_Rat_AMI_Dataset.pdf 6309
15 bmdj.01108_legal_challenges.pdf 5905
16 posture.05.pdf 5644
17 bmdj.01101_oa_to_scien_info.pdf 5538
18 bmdj.01109_osl_platform.pdf 4389
19 bmdj.01100_editorial_pilot.pdf 4381
20 bmdj.01106_oa_cardiology_research.pdf 4286
21 bmdj.01204_Thyroid_Hormone_Ischemic_Stroke.pdf 4267
22 bmdj.01107_oa_drug_discovery.pdf 4222
23 bmdj.01104_clinical_brain_research.pdf 4165
24 bmdj.01105_oa_endocrine_research.pdf 3911
25 01200_Tsatsaronis.pdf 3882
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 (10) J.J.V. McMurray; S. Adamopoulos; S.D. Anker; A. Auricchio; M. Bohm; K. Dickstein; V. Falk; G. Filippatos; C. Fonseca; M.A. Gomez-Sanchez; T. Jaarsma; L. Kober; G.Y.H. Lip; A.P. Maggioni; A. Parkhomenko; B.M. Pieske; B.A. Popescu; P.K. Ronnevik; F.H. Rutten; J. Schwitter; P. Seferovic; J. Stepinska; P.T. Trindade; A.A. Voors; F. Zannad; A. Zeiher; J.J. Bax; H. Baumgartner; C. Ceconi; V. Dean; C. Deaton; R. Fagard; C. Funck-Brentano; D. Hasdai; A. Hoes; P. Kirchhof; J. Knuuti; P. Kolh; T. McDonagh; C. Moulin; B.A. Popescu; Z. Reiner; U. Sechtem; P.A. Sirnes; M. Tendera; A. Torbicki; A. Vahanian; S. Windecker; T. McDonagh; U. Sechtem; L.A. Bonet; P. Avraamides; H.A. Ben Lamin; M. Brignole; A. Coca; P. Cowburn; H. Dargie; P. Elliott; F.A. Flachskampf; G.F. Guida; S. Hardman; B. Iung; B. Merkely; C. Mueller; J.N. Nanas; O.W. Nielsen; S. Orn; J.T. Parissis; P. Ponikowski
Open-access and Structured Data in Drug Discovery Good Data Won't Guarantee Good Decisions, Increasing the Content of High-Content Screening: An Overview., Direct measurement of DNA affinity landscapes on a high-throughput sequencing instrument, A Handbook for DNA-Encoded Chemistry: Theory and Applications for Exploring Chemical Space and Drug Discovery (7) Y. Zhang
Thyroid hormone improves the mechanical performance of the post-infarcted diabetic myocardium: A response associated with up-regulation of Akt/mTOR and AMPK activation (8) I. Mourouzis; I. Giagourta; G. Galanopoulos; P. Mantzouratou; E. Kostakou; A.D. Kokkinos; N. Tentolouris; C. Pantos
Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. (11) A.C. Bianco; D. Salvatore; B. Gereben; M.J. Berry; R. Larsen
Thyroid Hormone Deiodinases and Receptors Are Expressed in Human Endothelial Cells The thyroid and the heart, Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases., Cloning and Characterization of Two Novel Thyroid Hormone Receptor beta Isoforms, Molecular Aspects of Thyroid Hormone Actions, Type I iodothyronine deiodinase is a selenocysteine-containing enzyme, Cloning and in vitro expression of the human selenoprotein, type I iodothyronine deiodinase., Deiodination of Thyroid Hormone by Human Liver, Regional Distribution of Type 2 Thyroxine Deiodinase Messenger Ribonucleic Acid in Rat Hypothalamus and Pituitary and Its Regulation by Thyroid Hormone, A study of iodothyronine 5′-monodeiodinase activities in normal and pathological tissues in man and their comparison with activities in rat tissues, A Radioimmunoassay for Type I Iodothyronine 5'-Monodeiodinase in Human Tissues, Involvement of tyrosine phosphorylation in the regulation of 5'-deiodinases in FRTL-5 rat thyroid cells and rat astrocytes., Type 2 Iodothyronine Selenodeiodinase Is Expressed throughout the Mouse Skeleton and in the MC3T3-E1 Mouse Osteoblastic Cell Line during Differentiation, Type 3 Iodothyronine Deiodinase Is Highly Expressed in the Human Uteroplacental Unit and in Fetal Epithelium, A 21-Year-Old Woman with Consumptive Hypothyroidism due to a Vascular Tumor Expressing Type 3 Iodothyronine Deiodinase, Severe Hypothyroidism Caused by Type 3 Iodothyronine Deiodinase in Infantile Hemangiomas, Thyroid hormone deiodinases D1, D2, and D3 are expressed in human endothelial dermal microvascular line: effects of thyroid hormones, HMEC-1: establishment of an immortalized human microvascular endothelial cell line., Induction of type III deiodinase activity in astroglial cells by thyroid hormones., Regulation of Type 3 Iodothyronine Deiodinase Expression in Cultured Rat Astrocytes: Role of the Erk Cascade, Type 2 iodothyronine selenodeiodinase is express throughout the mouse skeleton and in the MC3T3-E1 mouse osteoblastic cell line during differentiation. Endocrinology., Effects of hyperthyroidism on vascular contractile and relaxation responses., Thyroid Hormone Regulates Type I Deiodinase Messenger RNA in Rat Liver, Pituitary cells respond to thyroid hormone by discrete, gene-specific pathways., Ontogeny of Iodothyronine Deiodinases in Human Liver, Type 1 iodothyronine deiodinase in human physiology and disease: Deiodinases: the balance of thyroid hormone, Thyroid hormones and skeletal muscle—new insights and potential implications, The Effects and Interactions of Substrates, Inhibitors, and the Cellular Thiol- Disulfide Balance on the Regulation of Type II Iodothyronine 5′-Deiodinase*, Thyroid Hormones Inhibit Type 2 Iodothyronine Deiodinase in the Rat Cerebral Cortex by Both Pre- and Posttranslational Mechanisms, Selective Proteolysis of Human Type 2 Deiodinase: A Novel Ubiquitin-Proteasomal Mediated Mechanism for Regulation of Hormone Activation, The mRNA Structure Has Potent Regulatory Effects on Type 2 Iodothyronine Deiodinase Expression, Triiodothyronine is required for the stimulation of type II 5′-deiodinase mRNA in rat brown adipocytes, Type 2 iodothyronine deiodinase in rat pituitary tumor cells is inactivated in proteasomes., A thyroid hormone-regulated gene in Xenopus laevis encodes a type III iodothyronine 5-deiodinase., Acute pretranslational regulation of type III iodothyronine deiodinase by growth hormone and dexamethasone in chicken embryos, Regulation of Thyroid Hormone Receptor Isoforms in Physiological and Pathological Cardiac Hypertrophy, Proangiogenic Effect of TSH in Human Microvascular Endothelial Cells through Its Membrane Receptor, Acute Effects of Thyroid Hormone on Vascular Smooth Muscle, Thyroid Hormone Promotes Remodeling of Coronary Resistance Vessels, Thyroid hormone stimulates NO production via activation of the PI3K/Akt pathway in vascular myocytes, Acute Effects of Triiodothyronine on Endothelial Function in Human Subjects (3) L. Sabatino; S. Balzan; V. Lubrano; G. Iervasi
Anaemia as Predictor of All-Cause Mortality in Patients with Systolic Dysfunction Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE), Anemia and Associated Clinical Outcomes in Patients With Heart Failure Due to Reduced Left Ventricular Systolic Function, The Economic Burden of Anemia in Heart Failure, Anemia associated with chronic heart failure: current concepts, Report of WHO/UNICEF/UNU consultation on indicators and strategies for iron deficiency and anemia programmes, Oxidative stress as a predictor of cardiovascular events in coronary artery disease patients, The Need for Open-access Structured Data in Cardiology Research, Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis, Anemia in chronic heart failure: pathogenetic mechanisms., Anemia in Chronic Heart Failure: Prevalence, Etiology, Clinical Correlates, and Treatment Options, ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012, Association between anaemia and N-terminal pro-B-type natriuretic peptide (NT-proBNP): findings from the Heart and Soul Study., Anaemia and renal dysfunction are independently associated with BNP and NT-proBNP levels in patients with heart failure, Endotoxin and immune activation in chronic heart failure: a prospective cohort study., The regulation and measurement of plasma volume in heart failure., Iron status in patients with chronic heart failure, Suicidal erythrocyte death, eryptosis, as a novel mechanism in heart failure-associated anaemia, Automation and validation of a fast method for the assessment of in vivo oxidative stress levels, Risk of bias in meta-analysis on erythropoietin-stimulating agents in heart failure, Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial, Inhibitory Effect of Thymol on Suicidal Erythrocyte Death, Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume (8) C. Vassalle; A. Vannucci; F. Mastorci; D. Battaglia; P. Landi; P. Di Cecco; C. Carpeggiani
Heart failure post-myocardial infarction: a review of the issues (5) H. Dargie
Percutaneous vascular stent: experimental studies and preliminary clinical results in peripheral arterial diseases. (2) H. Rousseau; J. Joffre; J. Puel; C. Imbert; J.L. Puech; C. Duboucher; H. Wallsten
Relating circulating thyroid hormone concentrations to serum interleukins-6 and -10 in association with non-thyroidal illnesses including chronic renal insufficiency (22) H.A. Abo-Zenah; S.A. Shoeb; A.A. Sabry; H.A. Ismail
Inhibition of induced chemoresistance by cotreatment with (E)-5-(2-bromovinyl)-2'-deoxyuridine (RP101). (2) R. Fahrig; J.C. Heinrich; B. Nickel; F. Wilfert; C. Leisser; G. Krupitza; C. Praha; D. Sonntag; B. Fiedler; H. Scherthan; H. Ernst

Pages

Share